Authors:
Moins, N
Cayre, A
Chevillard, S
Maublant, J
Verrelle, P
Finat-Duclos, F
Citation: N. Moins et al., Effects of MDR reversing agent combinations on the H-3-daunomycin accumulation in drug-sensitive and drug-resistant human cancer cells, ANTICANC R, 20(4), 2000, pp. 2617-2623
Authors:
Dionet, C
Tchirkov, A
Alard, JP
Arnold, J
Dhermain, J
Rapp, M
Bodez, V
Tamain, JC
Monbel, I
Malet, P
Kwiatkowski, F
Donnarieix, D
Veyre, A
Verrelle, P
Citation: C. Dionet et al., Effects of low-dose neutrons applied at reduced dose rate on human melanoma cells, RADIAT RES, 154(4), 2000, pp. 406-411
Authors:
Bay, JO
Uhrhammer, N
Pernin, D
Presneau, N
Tchirkov, A
Vuillaume, M
Laplace, V
Grancho, M
Verrelle, P
Hall, J
Bignon, YJ
Citation: Jo. Bay et al., High incidence of cancer in a family segregating a mutation of the ATM gene: Possible role of ATM heterozygosity in cancer, HUM MUTAT, 14(6), 1999, pp. 485-492
Authors:
Cayre, A
Moins, N
Finat-Duclos, F
Maublant, J
Verrelle, P
Citation: A. Cayre et al., Comparative Tc-99m-sestamibi and H-3-daunomycin uptake in human carcinoma cells: Relation to the MDR phenotype and effects of reversing agents, J NUCL MED, 40(4), 1999, pp. 672-676
Authors:
Rolhion, C
Penault-Llorca, F
Kemeny, JL
Kwiatkowski, F
Lemaire, JJ
Chollet, P
Finat-Duclos, F
Verrelle, P
Citation: C. Rolhion et al., O-6-methylguanine-DNA methyltransferase gene (MGMT) expression in human glioblastomas in relation to patient characteristics and p53 accumulation, INT J CANC, 84(4), 1999, pp. 416-420
Authors:
Rolhion, C
Penault-Llorca, F
Chevillard, S
Verrelle, P
Finat-Duclos, F
Citation: C. Rolhion et al., Quantification of RT-PCR products - Ethidium bromide-stained gel analysis compared with fluorescent detection using an automated sequencer, LAB MED, 30(6), 1999, pp. 419-422